κ isotype (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
98
Structured Review
Bio X Cell
κ isotype
κ Isotype, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 98/100, based on 1812 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+igg2a/InVivoMAb+rat+IgG2a+isotype+control%2C+anti-trinitrophenol/pm42907443-548-8-11
Average 98 stars, based on 1812 article reviews
κ Isotype, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 98/100, based on 1812 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+igg2a/InVivoMAb+rat+IgG2a+isotype+control%2C+anti-trinitrophenol/pm42907443-548-8-11
Average 98 stars, based on 1812 article reviews
κ isotype - by Bioz Stars,
2026-10
98/100 stars
Images
Related Articles
Control:Article Title: GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma Article Snippet: 349 For in vivo CD8 depletion studies, anti-CD8 antibody (10mg/kg, # BE0117, clone YTS 169.4, 350 BioXcell) or rat IgG2a (#BE0089, BioXcell) treatment was administered to C57BL/6J male or 351 female mice one day before surgery and then administered intraperitoneally every 7 days post-352 surgery for 4 cycles. .. 354 For immune checkpoint blockade treatment, mice were intraperitoneally administered 100 μg of 355 anti-PD-1 antibody (#BE0146, clone RMP1-14, BioXcell) every 3 days for a total of 7 doses 356 since Day 1, with Article Title: PD-1 inhibitor improves radiosensitivity by tumor vessel normalization Article Snippet: .. For antibody depletion experiments, animals received 250 μg of depleting or isotype control monoclonal antibodies, including CD4 (clone YTS177, #BE0003-3, BioXCell), CD8 (clone 53-6.7, #BE0004-1, BioXCell), and Article Title: PD-1 inhibitor improves radiosensitivity by tumor vessel normalization. Article Snippet: .. For antibody depletion experiments, animals received 250 μg of depleting or isotype control monoclonal antibodies, including CD4 (clone YTS177, #BE0003-3, BioXCell), CD8 (clone 53-6.7, #BE0004-1, BioXCell), and Article Title: CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells Article Snippet: When tumor volumes reached 75 to 125 mm 3 , the mice were randomized into 4 treatment groups: (a) anti-mouse CTLA-4 (BP0032, clone UC10-4F10-11, Bio X Cell), (b) anti-mouse PD-1 (BE0146, clone RMP1-14, Bio X Cell), (c) a combination of anti-CTLA-4 and anti-PD-1, and (d) control antibodies. .. Article Title: CEBPB expression in tumor cells drives immune evasion in colorectal cancer via CTLA4 upregulation in T cells Article Snippet: When tumor volumes reached 75–125 mm3, the mice were randomized into four treatment groups: 1) antimouse CTLA-4 (BP0032, clone UC10-4F10-11, Bio X Cell), 2) anti-mouse PD-1 (BE0146, clone RMP1-14, Bio X Cell), 3) a combination of anti-CTLA-4 and antiPD-1, and 4) control antibodies. .. Bioprocessing:Article Title: PD-1 inhibitor improves radiosensitivity by tumor vessel normalization Article Snippet: .. For antibody depletion experiments, animals received 250 μg of depleting or isotype control monoclonal antibodies, including CD4 (clone YTS177, #BE0003-3, BioXCell), CD8 (clone 53-6.7, #BE0004-1, BioXCell), and Article Title: PD-1 inhibitor improves radiosensitivity by tumor vessel normalization. Article Snippet: .. For antibody depletion experiments, animals received 250 μg of depleting or isotype control monoclonal antibodies, including CD4 (clone YTS177, #BE0003-3, BioXCell), CD8 (clone 53-6.7, #BE0004-1, BioXCell), and |